Dutch Project To Monitor Safety Of Biosimilar Switching
This article was originally published in SRA
Executive Summary
The Dutch government has taken another step in its efforts to promote the uptake of biosimilar medicines by asking the national pharmacovigilance centre Lareb to pilot a national system for monitoring switches among originator drugs and biosimilars1.